Accused of forming a patent thicket around its top-seller Humira and cancer blockbuster Imbruvica, AbbVie has faced repeated pressure from the House Committee on Oversight and Reform to layout its pricing and patenting strategies. With that information now in hand, the committee is putting AbbVie’s helmsman in the hot seat.
Photo Credits: AbbVie
Note: A version of this article about insurance premium increases appeared in our LinkedIn newsletter, Pricing Power Clarity®. Trust Buffett, it’s a great business It’s no wonder Warren Buffett loves
.Note: A version of this article appeared in our LinkedIn newsletter, Pricing Power Clarity®. The “classic” price value maps – refresher & setup In my “part 1” of this post I
Note: A version of this article was published in our LinkedIn newsletter, Pricing Power Clarity®. Pricing power – defined broadly In our previous newsletter installments, we proposed expanding the accepted meaning
